NORTHEAST OHIO VA HEALTHCARE SYSTEM BEST PRACTICE RECOGNITION/MANAGEMENT OF HYPOGLYCEMIA

Similar documents
Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy

A Diabetes Update: Hypoglycemic Safety

Non-insulin treatment in Type 1 DM Sang Yong Kim

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes

7/28/17. Objectives: Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern. Disclaimer:

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

123 Are You Providing Evidence-Based Diabetes Care? - Martin

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by (Vale of York CCG/date)

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

Dr Karen McNeil Consultant Endocrinologist

OLD AND NEW DRUGS FOR CONTROLING DIABETES THERAPEUTIC CLASSES AND MECHANISM OF ACTION

Multiple Factors Should Be Considered When Setting a Glycemic Goal

Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors Drug Class Prior Authorization Protocol

Media Contacts: Amy Rose Investor Contact: Graeme Bell (908) (908)

Joshua Settle, PharmD Clinical Pharmacist Baptist Medical Center South ALSHP Fall Meeting September 30, 2016

Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal

Glycemic Control IU Health Diabetes Centers

Common Diabetes-related Terms

CASE A2 Managing Between-meal Hypoglycemia

GLYCEMIC CONTROL SURVEY

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

What s New in Diabetes Medications. Jena Torpin, PharmD

Merck & Co, Inc. Announced Approval of JANUVIA TM (INN: sitagliptin), a new oral treatment of diabetes, by the US FDA

THE SHADOW OF DIABETES CARE IN OLDER ADULTS FRANCISCO DIAZ GNP-BC, CDE

National Horizon Scanning Centre. Saxagliptin (BMS ) for type 2 diabetes. April 2008

SGLT2 Inhibitors

LIBERTYHEALTH. Jersey City Medical Center Department of Patient Care Services. Approved by Policy Committee:

Glucagon Administration. Molalla River School District

WHO Guidelines for Management of Diabetes in Low Resource Settings

MOA: Long acting glucagon-like peptide 1 receptor agonist

CADTH THERAPEUTIC REVIEW New Drugs for Type 2 Diabetes: Second-Line Therapy Recommendations Report

Drug Class Monograph

Metabolic Syndrome: What s so big about BIG?

VICTOSA and Renal impairment DR.R.S.SAJAD

Drug Class Monograph

This program applies to Commercial, GenPlus and Health Insurance Marketplace formularies.

ABOUT TYPE 2 DIABETES

A Clinical Context Report

HYPOGLYCEMIA: Prevention, Recognition and Treatment in Residential and Acute Care Self Learning Plan

GLP-1 (glucagon-like peptide-1) Agonists (Byetta, Bydureon, Tanzeum, Trulicity, Victoza ) Step Therapy and Quantity Limit Criteria Program Summary

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Volume : 05 Issue : 03 July-Sept Pages:

HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN. Kacy Aderhold, MSN, APRN-CNS, CMSRN

Diabetes and Kids- Keeping them Safe at School. Presented by Vanessa Skolness, DNP, APRN-CNP, CDE March 30 th, Diabetes Summit

CHRONIC KIDNEY DISEASE WHY WOMEN MAY BE AT RISK?

APPENDIX American Diabetes Association. Published online at

Diabetes Medications: Oral Anti-Hyperglycemic Medications

Current evidence on the effect of DPP-4 inhibitor drugs on mortality in type 2 diabetic (T2D) patients: A meta-analysis

Application of the Diabetes Algorithm to a Patient

Empagliflozin (Jardiance ) for the treatment of type 2 diabetes mellitus, the EMPA REG OUTCOME study

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives

DIABETES MANAGEMENT DISCHARGE COMMUNICATION (DM-DC) AUDIT TOOL

Cardiovascular Benefits of Two Classes of Antihyperglycemic Medications

New Drugs for Type 2 Diabetes: Second-Line Therapy Recommendations Report

Optimal glucose control. DM Treatment. Glucose Control one out of many. Many guidelines: Confusing. Theorectically easy

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

NOT-SO-SWEET! THE STRAIGHT SCOOP ON DIABETES IN THE HOSPITAL SETTING

SGLT2 Inhibitors

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

Hypoglycemia Reduction STARTER PACK WEBINAR #1

Type. Diabetes Drugs. A Review

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

Key Elements in Managing Diabetes

Combination treatment for T2DM

Index. Note: Page numbers of article titles are in boldface type.

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Soliqua 100/33. (insulin glargine, lixisenatide) New Product Slideshow

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND THE OLDER ADULT

Soliqua (insulin glargine and lixisenatide), Xultophy (insulin degludec and liraglutide)

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate

Type Two Diabetes Mellitus Prescribing in New Zealand - What are we dispensing?

Diabetes, Drugs and Dangerous Discrepancies. Sally Bodenhamer, OD, OT/L, CDE

Diabetes Complications Recognition and Treatment

Correlates of second-line type 2 diabetes medication selection in the USA

Essential advice for people with diabetes from Accu-Chek. The inside story on diabetes

diabetes and you your guide to better living with diabetes

Hypoglycemia. Patient Education Diabetes Care Center. How to cope with low blood sugar. General Facts on Low Blood Sugar. Causes

Essential advice for people with diabetes from Accu-Chek. Get the low-down on hypos

DKA Adult ICU Powerplan

Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

New and Emerging Therapies for Type 2 DM

Control of Blood Glucose in the ICU: Reconciling the Conflicting Data

GLP 1 agonists Winning the Losing Battle. Dr Bernard SAMIA. KCS Congress: Impact through collaboration

The TRUE Guide to Diabetes Care

Therapeutic strategy to reduce Glucagon secretion


Special thanks to the EJC Foundation for their support of Sanford Center Geriatric Specialty Clinic

CADTH Optimal use report

Physical Activity/Exercise Prescription with Diabetes

Insulin Initiation and Intensification. Disclosure. Objectives

A Children s Bedtime Story

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

A randomised controlled clinical trial in type 2 diabetes comparing semaglutide to placebo and liraglutide

Transcription:

NORTHEAST OHIO VA HEALTHCARE SYSTEM BEST PRACTICE RECOGNITION/MANAGEMENT OF HYPOGLYCEMIA Joint Commission Inpatient Diabetes Team Sharon A. Watts DNP, FNP-BC, CDE Drina Nemes MSN, CNS, CRRN Amanda Pensiero MD

Objectives: Learner will be able to: Define Hypoglycemia. Set safe blood glucose goals. Identify Hypoglycemia risk factors. Recognize the signs and symptoms of Hypoglycemia. Explain the 15-15 rule.

Cleveland VA Inpatient Diabetes Certification The Northeast Ohio has maintained Joint Commission Inpatient Diabetes Certification since 2008 (an honor that only 1% of U.S. hospitals currently hold and no other VA Hospital!) and as such we need your commitment to uphold our diabetes standards. Our focus is on Veteran safety with early recognition, rapid management and prevention of hypoglycemia. We have a listing of our diabetes protocols and guidance for best care on the Pharmacy Website: Northeast Oho VA Healthcare Systems Pharmacy Website

What is Hypoglycemia? Hypoglycemia, or low blood glucose, occurs when the level of glucose in the blood drops below normal For many people with diabetes, that means a level of 70 milligrams per deciliter (mg/dl) or less Can be a side effect of insulin or other diabetes medications that cause the body to produce insulin U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. (2016.). Low Blood Glucose (Hypoglycemia) Retrieved from https://www.niddk.nih.gov/health-information/diabetes/preventingdiabetes-problems/low-blood-glucose-hypoglycemia

Set Safe Blood Glucose Goals

The Lurking Dangers of Hypoglycemia

Safety Concerns Brodovich KG et al. Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin. 2013;29(2): 101-107. SALIBA, L; et al. Medication-induced and spontaneous hypoglycemia carry the same risk for hospital mortality in critically ill patients.

Serious Sequela of Hypoglycemia! More recent research over the past decade indicates that Hypoglycemia is not as benign as we thought in the past. Take a look at this potential list of Sequelae of Hypoglycemia: Serious Sequelae: Tachycardia Bradyarrhythmias ST Depression T-wave Flattening QT Prolongation Hypokalemia Severe Hypertension Falls Death

NICE Sugar Study Multi-site Inpatient ICU International Randomized Control Trial Conclusion: Mortality Increased by in tight 80-108 mg/dl glucose control group verses 144-180 mg/dl in the conventional arm N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24

Risk Factors for Hypoglycemia Intensive glucose control/a1c targets Advanced age or cognitive impairment Low health literacy/numeracy Food insecurity (uncertain access to adequate food) Low economic status Prior hypoglycemic episode Hypoglycemia unawareness Liver/kidney disease Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2013;37(suppl 1):S1-S212.

Risk of Hypoglycemia by DM Medication TZD: Thiazolidinediones; DPP-4: Dipeptidyl peptidase-4; SGLT-2: Sodium-glucose cotransporter 2; GLP-1: Glucagon-like peptide-1 Diabetes Care 2017;40(Suppl. 1):S64 S74

Symptoms of Hypoglycemia Caution-signs/symptoms may be muted if on Beta-blocker therapy so err on the side of caution U.S. Department of Veterans Affairs (2016). Hypoglycemia Safety Initiative. Retrieved from http://www.qualityandsafety.va.gov/choosingwiselyhealthsafetyinitiative/hypoglycemiasite/for_clinicians.asp

Hypoglycemia Severity by Symptoms

Hypoglycemia Severity by Number Hypoglycemia < 70mg/dL Severe Hypoglycemia > 50mg/dL

15-15 Hypoglycemia Treatment Repeat

Avoid Possible Aspiration-Never Force Glucose into an Unconscious Patient s Mouth! If the patient is unable to swallow, or unable to receive treatment orally, (i.e., Nothing by Mouth (NPO) status) follow the protocol for the severe form of hypoglycemia.

Notify Provider for Repeated Hypoglycemia Insulin may need to be changed Data is collected to drive change See Northeast Ohio VA Healthcare System s Medical Center Policy 118-047 Hypoglycemia Management: Link to MCP 118-047

Nurses-Remember to Chart Event!

Nursing Hypoglycemia Reference Card

Inpatient Hypoglycemia Nursing Competency For Inpatient Hypoglycemia Nursing Competency & other Diabetes Products: Office of Nursing Services Clinical Products Pagehttp://vaww.va.gov/nursing/cppP roducts.asp listed under Metabolic Syndrome & Diabetes----->View Products